First-In-Human Study in Subjects With Advanced or Metastatic Solid Malignant Tumors
Clinical trial NCT05494918 · COMPLETED
Trial details
- NCT number
- NCT05494918
- Sponsor
- Alphamab (Australia) Co Pty Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-02
- Primary completion
- 2025-04-15
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.